Research Article: Exploring Real-World HER-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications
Introduction:
Boundaries of breast cancer subtypes definition based on Human Epidermal Growth Factor Receptor (HER) status have never been so intensely debated so far. The immunohistochemistry classification of breast cancer, which has traditionally been used for systemic treatment sequencing and surgical treatment strategies, still relies on the status of hormone receptors and HER. , HER status has conventionally been classified dichotomously, based on the expression of immunohistochemistry (IHC) and amplification by in situ…
Read more